Claims here about purity and testing refer to Axis Peptide Labs products, which are for laboratory research use only
As GLP-1 agonists have garnered attention for management of obesity due to their effect on reducing insulin sensitivity, they are now being considered a therapeutic option for the treatment of PCOS (polycystic ovarian syndrome), one of the most common causes of subfertility, diagnosed via Rotterdams criteria: oligomenorrhea, hyperandrogenism and polycystic ovaries (97)
For scientists, thats a big deal because its exactly the type of ability that can lead to better drugs
This is exactly where peptide research becomes relevant
It has emerged as a critical and rapidly growing public health concern, affecting an estimated 537 million individuals in 2022
Poor sleep disrupts hormone balance, increasing cravings for unhealthy foods